专利摘要:
Certain 7-acylamido-3-[1-carboxymethyl-(or ethyl- or propyl-)-tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids and their salts and easily hydrolyzed esters of the 4-carboxyl group were synthesized and found to be potent antibacterial agents which exhibited good aqueous solubility. A preferred embodiment was 7-(2-aminomethylphenylacetamido)-3-(1-carboxymethyltetrazol-5-ylthiome thyl)-3-cephem-4-carboxylic acid.
公开号:SU867310A3
申请号:SU762388803
申请日:1976-08-13
公开日:1981-09-23
发明作者:Дж.Готтстейн Уильям;А.Каплан Мюррэй;П.Гранатек Альфонс
申请人:Бристоль Мейерз Компани (Фирма);
IPC主号:
专利说明:

can vary from yellow to dark brown.
Pass the product through a 200 mesh stainless sieve.
10 g of 200 mesh powder are suspended in 200 ml of propanol with vigorous stirring.
2.0 ml of concentrated HC1 is added and stirred vigorously for 0.5 h at room temperature.
The suspension is filtered, the brown precipitate is washed with 20 ml of propanol and the rinsing is added to the filtrate {the filter cake is kept to isolate the additional product).
1.5 g of charcoal is added to the propanol filtrate (Darko G-60 | and vortexed for 0.5 hours. The carbon is filtered off, washed with 20 ml of propanol and the washing is added to the filtrate.
With rapid stirring, triethylamine is added to the pH of 3.0 to the propanol filtrate. Crystals are formed which are stirred up for 10 minutes.
White crystals are collected by filtration, in 5 ml of propanol, 50 ml of methanol and dried under vacuum at 40 ° C for 24 hours. 4-8 g of 7-amino-3 {-) (1-carboxymethyltetrazol-5-nlthiomethyl) - are obtained. 3-cephem-4-carboxylic acid.
Another method for the purification of 7-amino-C-) (1-carboxymethyltetrazo-5-yl-methylmethyl 3-cephem-4-carboxylic acid is as follows.
At room temperature, 10 to 15 minutes are boiled over 10 g of the product with 200 mesh. (from stage lOj in 75 ml of 1N HCl, then 2.5 g of coal (Darko G-60) is added to filter udgsheni of dark brown substances and stirred for 0.5 h. The coal is separated by filtration and washed with 15 ml of water, l lAdBKy with rapid stirring, concentrated ammonium hydroxide is added to a pH of 2.5-3.0 with rapid stirring, a crystalline mass is formed, which is stirred for 25 minutes and the crystals are filtered off, washed with 30 ml of water, 50 ml of methanol and dried in vacuo at at room temperature, 4-7 g of almost white crystals.
 . EXAMPLE 2: 7-Amino-3 (-K1-carboxymethyltetraz6l-5-ylthiomethyl | -3-cephem-4-carboxylic acid.
To a suspension of 22 g (0.081 mol) of 7-aminocephalosporanic acid in 350 mol (pH 6.4) of 0.1 M phosphate buffer, 14.4 g (0.089 mol of 1 - carboxymethyl-5-mercaptoterazole and 1.5 g of bisulfite The mixture is heated under nitrogen to 55 ° C, solid sodium bicarbonate is added until the mixture is clear (pH 7.5). The solution is heated for 3.5 hours, cooled to 10 ° C and adjusted to pH 2 with bn salt
acid. The precipitate is collected, washed with cold water and then with methanol and air dried, which gives 16.2 g of 7-amino-3 (-) 1-carboxymethyltetrazol-5-ylthiomethyl 3-cephem-4-carboxylic acid. The sample is recrystallized from 100 ml of methanol with concentrated hydrochloric acid, which is added dropwise until the mixture is clear. The solution was adjusted to pH 5 with concentrated ammonium hydroxide, and the precipitate was collected in an amount of 6.2 g. Spectra NMR and infrared correspond to this structure.
Froze 7-amino-3 {-X1-carbo 5 xymethyltetrazol-5-yl-methyl; -3-cephem-4-carboxylic acid.
To a nitrogen-purified solution of 1.5 g (1,, 4 sodium bisulfite in 350 ml {pI 6.4) phosphate buffer was added 22 g (8.1 h102 mol) of 7-aminocephalosporanic acid, 14, 315 g (ECU) 1- carboxymethyl-5-mercaptoterazole and enough sodium bicarbonate to form
5 clear solution. Reactionary
the mixture is kept for 3.5 hours under a rapid stream of nitrogen, then cooled to. The pH is adjusted to 2.5 with ps. 6 n. hydrochloric acid
“And the mixture is stirred in an ice bath, which promotes precipitation. The product is collected and washed with cold water, methanol and aceton, recrystallized from a mixture of methanol - hydrochloric acid and dried in vacuum over
P-lOs at. the product yield is 62 g. The NMR spectrum and infrared correspond to the structure.
EXAMPLE 4 7-Amino-31-K1-carboxymethyltetrazol-5-ylthiomethyl) -30-cefem-4-carboxylic acid.
To a mixture of 4.6 g (0.0286 mol) of 5-mercaptotetrazol-acetic acid and 7.8 g (0.0286 mol) of 7-aminocephalosporanic acid in 150 ml of 0.1 M phosphate buffer (pH 6.4) is added with stirring bicarbonate sodium until the solution is clear (pH 7.5). The solution is heated at 55 ° C under nitrogen for 4 hours and oxidized with a mixture of
Q and water in a 1: 1 ratio. The precipitate is collected, washed with a veda, and then with a small amount of methanol. The solid is then suspended with 150 ml of methanol and concentrated hydrochloric acid added in apls until the solution becomes clear. The solution is treated with carbon, filtered and neutralized with concentrated ammonium hydroxide to pH 4.5. The solid is collected, washed with methanol and prepared with 5.0 g of product. The NMR and infrared spectra correspond to the structure.
权利要求:
Claims (1)
[1]
The invention The method of obtaining 7-amino-3 (-) {1-car5 bauximethyltetrazol-5-ylthiomethyl) -35 8673106
- cefvm-4-carboxylic acid, about t and i-hepaxype from 18 to at pH 5,5 h and y and with the fact that 7-amino-D, 5.
- cephalosporic acid or her
salt is subjected to interaction with sources of information, 5-mercaptotetrazolyl 1 acetic acid is taken into account during the examination
lot in the medium of the solvent, the same 1. Patent .USA Application for
like water or water aiieTOMi, with that-1 2119549/04, cd. C 07 O 501 / 60,1974.
类似技术:
公开号 | 公开日 | 专利标题
SU867310A3|1981-09-23|Method of preparing 7-amino-3 |-|-3-cephem-4-carbohalic acid
KR840000866B1|1984-06-20|Process for preparing chephalosporin solvates
SU791246A3|1980-12-23|Method of preparing derivatives of 7-/2-|-2-alkoxyiminoacetamido/-3-cephem-4-carboxylic acid
SU654171A3|1979-03-25|Method of obtaining 7-d-/-/a-amino-a-/p-oxyphenylacetamido/-desacetoxycephalosporanic acid or its hydrate or its salt
SU1757468A3|1992-08-23|Method for preparation of crystalline 1-carbocephalosporine-2-water
SU1731058A3|1992-04-30|Antibiotic based on crystalline monohydrate form of 1-carbocephalosporin
RU1804461C|1993-03-23|Method of crystalline cefadroxyl monohydrate synthesis
SU1356963A3|1987-11-30|Method of producing alfa-form crystal monohydrate of bis-hydrobromide of cephtasidime
RU2134265C1|1999-08-10|Bicyclic complexes beta-lactam/hydroxybenzoic acid, methods of beta-lactams synthesis
US4525587A|1985-06-25|Process for preparing a cephalosporin compound
KR870000830B1|1987-04-23|Process of formic crystalline ceftazidime pentahydrate
SU576948A3|1977-10-15|Method of preparing cephalosporanic acid derivatives or salts thereof
SU458131A3|1975-01-25|The method of obtaining cipher bases of 7-amino-3-desatzfetoxycephalosporanic acid
RU2002749C1|1993-11-15|Method for preparing crystal bis-|-1-carbocephalosporin hydrate
FI74709B|1987-11-30|TRIMETHYLSILYLOXYCARBONYL-7-AMINODECEFALOSPORANSYRA-TRIMETHYLSILYLESTER FOR OIL MUSHROOMS AND OIL PRODUCTS FOR FRAMSTAELLNING AV DENNA.
SU793387A3|1980-12-30|Method of preparing substituted amides or their salts
US5410044A|1995-04-25|Process for preparing Z and E-rotamers of 3-hydroxy cephem derivatives
SU784780A3|1980-11-30|Method of preparing d-isomers of penicillin derivatives or their pharmaceutically employed salts
SU574158A3|1977-09-25|Method of preparing cephalexine or salts thereof
US3843642A|1974-10-22|Cephalosporin c derivatives
US4659812A|1987-04-21|Cephalosporin intermediates
SU383302A1|METHOD FOR OBTAINING DERIVATIVES OF CEFA-SPORANO
SU953983A3|1982-08-23|Process for producing cephalosporin derivatives
US3644377A|1972-02-22|Process for the preparation of |acetic acid
SU552903A3|1977-03-30|The method of obtaining derivatives of 6-trichloroacetamidopenicillanic acid
同族专利:
公开号 | 公开日
JPS525787A|1977-01-17|
JPS60185788A|1985-09-21|
JPS6157316B2|1986-12-06|
JPS6150957B2|1986-11-06|
IL61566D0|1980-12-31|
US4100346A|1978-07-11|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题

US3819623A|1968-04-12|1974-06-25|Fujisawa Pharmaceutical Co|3,7-disubstituted cephalosporin compounds|US4297489A|1974-09-03|1981-10-27|Bristol-Myers Company|7-α-Amino-substituted acylamino-3--3-cephem-4-carboxylic acids|
US4286089A|1974-12-27|1981-08-25|Smithkline Corporation|7-Acyl-3-cephalosporins|
US4220644A|1976-05-03|1980-09-02|Smithkline Corporation|7-Acylamino-3- cephalosporins|
US4189573A|1976-11-02|1980-02-19|Smithkline Corporation|7-Amino-3-cephalosporins|
FR2387235B1|1978-01-23|1981-11-06|Fujisawa Pharmaceutical Co|
DK225179A|1978-06-22|1979-12-23|Chugai Pharmaceutical Co Ltd|PROCEDURE FOR PREPARING CEPHALOSPORINE DERIVATIVES|
US4223135A|1979-03-19|1980-09-16|Bristol-Myers Company|Production of cephalosporins|
US4316017A|1979-03-19|1982-02-16|Bristol-Myers Company|Cephalosporin intermediates|
US4316016A|1979-03-19|1982-02-16|Bristol-Myers Company|Cephalosporin intermediates|
US4243803A|1979-07-05|1981-01-06|Bristol-Myers Company|Production of 7--3--3-cephem-4-carboxylic acid|
US4420477A|1979-11-30|1983-12-13|Fujisawa Pharmaceutical Co., Ltd.|Cephem compounds|
US4346076A|1980-09-17|1982-08-24|Eli Lilly And Company|Bis-tetrazoylmethyl substituted cephalosporin antibiotics|
US4448958A|1982-10-20|1984-05-15|Bristol-Myers Company|Purification of ceforanide|
BRPI0512963A|2004-06-30|2008-04-22|Dsm Ip Assests Bv|product comprising a-lactam antibiotic|
WO2008010043A2|2006-07-18|2008-01-24|Orchid Chemicals & Pharmaceuticals Limited|Improved process for the preparation of ceforanide in pure form|
CN102898442A|2012-10-25|2013-01-30|河南中帅医药科技发展有限公司|Refinement method of ceforanide|
CN112043835A|2013-12-06|2020-12-08|韩捷|Bioreversible introducing group for nitrogen and hydroxyl-containing drugs|
法律状态:
优先权:
申请号 | 申请日 | 专利标题
US05/590,971|US4297489A|1974-09-03|1975-06-27|7-α-Amino-substituted acylamino-3--3-cephem-4-carboxylic acids|
[返回顶部]